Coya Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COYA research report →
Companywww.coyatherapeutics.com
Coya Therapeutics, Inc. , a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.
- CEO
- Arun Swaminathan
- IPO
- 2022
- Employees
- 8
- HQ
- Houston, TX, US
Price Chart
Valuation
- Market Cap
- $84.12M
- P/E
- -3.66
- P/S
- 10.60
- P/B
- 0.00
- EV/EBITDA
- 2317.79
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.79%
- Op Margin
- -277.02%
- Net Margin
- -266.11%
- ROE
- -0.17%
- ROIC
- -0.04%
Growth & Income
- Revenue
- $7.95M · 123.57%
- Net Income
- $-21,226,107 · -42.64%
- EPS
- $-1.27 · -29.59%
- Op Income
- $-20,265,623
- FCF YoY
- -4.38%
Performance & Tape
- 52W High
- $7.75
- 52W Low
- $3.71
- 50D MA
- $4.37
- 200D MA
- $5.37
- Beta
- 0.55
- Avg Volume
- 153.19K
Get TickerSpark's AI analysis on COYA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 9, 26 | Pavao Mark H | other | 10,000 |
| Apr 1, 26 | Pavao Mark H | other | 0 |
| Jan 22, 26 | SNYDER DAVID S | other | 140,041 |
| Jan 22, 26 | Grossman Fred | other | 140,041 |
| Jan 22, 26 | Berman Howard | other | 15,257 |
| Jan 22, 26 | Swaminathan Arun | other | 293,983 |
| Jan 2, 26 | Villalobos Anabella | other | 10,000 |
| Jan 2, 26 | GOLDSTEIN DOV A MD | other | 10,000 |
| Jan 2, 26 | Weinand Dieter | other | 10,000 |
| Jan 2, 26 | ROSS WILBUR L JR | other | 10,000 |
Our COYA Coverage
We haven't published any research on COYA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate COYA Report →